Isolated human and animal stratum corneum as a partial model for the 15 steps of percutaneous absorption: Emphasizing decontamination, part II

Journal of Applied Toxicology

Volumn 33, Issue 3, 2013, Pages 173-182

  Hui, Xiaoying ^a   Lamel, Sonia ^a   Qiao, Peter ^a   Maibach, Howard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

15 steps in percutaneous absorption; Decontamination; Powdered stratum corneum; Rougier method; Wash rubbing effects

Indexed keywords

4 NITROANILINE; AROCLOR 1242; CHEMICAL WARFARE AGENT; COSMETIC; DERMATOTOXICANT; ESTRADIOL; GLYPHOSATE; HYPERTONIC SOLUTION; ISOTONIC SOLUTION; PESTICIDE; SODIUM CHLORIDE; TOXIC SUBSTANCE; UNCLASSIFIED DRUG; WATER;

ANATOMICAL VARIATION; ANIMAL TISSUE; CHEMICAL BINDING; CONCENTRATION (PARAMETERS); DIFFUSION; DISPERSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MORBIDITY; MORTALITY; NONHUMAN; PARTITION COEFFICIENT; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RADIOACTIVITY; REVIEW; RISK ASSESSMENT; SKIN ABSORPTION; SKIN DECONTAMINATION; SKIN EXFOLIATION; SKIN PENETRATION; SKIN PERMEABILITY; SKIN TOXICITY; SOLUBILITY; STRATUM CORNEUM; TISSUE DISTRIBUTION; URINARY EXCRETION;

ANIMALS; DECONTAMINATION; DIFFUSION; HUMANS; MODELS, BIOLOGICAL; SKIN; SKIN ABSORPTION; XENOBIOTICS;

ANIMALIA;

EID: 84873057193     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2826     Document Type: Review

References (51)

1. Asbill CS, Michniak BB. 2000. Percutaneous penetration enhancers: local versus transdermal activity. Pharm. Sci. Technol. Today. 3: 36-41.
2. Barry BW. 1983. Structure, function, diseases, and topical treatment of human skin. In Dermatological Formulations: Percutaneous Absorption, Barry BW (ed.). Marcel Dekker: New York; 1-48.
3. Benson HA. 2005. Transdermal drug delivery: Penetration enhancement techniques. Curr. Drug Deliv. 2: 23-33.
4. Braue EH, Doxzon BF, Lumpkin HL, Hanssen KA, Stevenson RS, Deckert RR, Graham JS. 2006. Military perspectives in chemical penetration retardation. In Percutaneous Penetration Enhancers, 2nd edn, Smith EW, Maibach H (eds). Taylor & Francis Group, LLC; 385-397.
5. Bronaugh RL, Congdon ER. 1984. Percutaneous absorption of hair dyes: correlation with partition coefficients. J. Invest. Dermatol. 83: 124-127.
6. Bucks DA, Wester RC, Mobayen MM, Yang D, Maibach HI, Coleman DL. 1989. In vitro percutaneous absorption and stratum corneum binding of alachlor: effect of formulation dilution with water. Toxicol. Appl. Pharmacol. 100: 417-423.
7. Chandrasekaran SK, Campbell PS, Watanabe T. 1980. Application of the 'dual sorption' model to drug transport through skin. Polym. Eng. Sci. 20: 36-39.
8. Chan HP, Zhai H, Hui X, Maibach. 2012. Skin Decontamination: Principles and Practices. Toxicol. Ind. Health. DOI: 10.1177/0748233712448112, Published online Jul 30.
9. Chattaraj SC, Walker RB. 1995. Penetration enhancer classification. In Percutaneous Penetration Enhancers, Smith EW, Maibach HI (eds). CRC Press: Boca Raton; 5-20.
10. Elias PM. 1983. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 80 (Suppl.): 44S-49S.
11. Federal Working Group on Pest Management. 1974. Occupational exposure to Pesticides - Report to the Federal Working Group on Pest Management from the Task Group on Occupational Exposure to Pesticides. Washing, DC.
12. Franklin SL, Geffner ME. 2003. Percocious puberty secondary to topical testosterone exposure. J. Pediatr. Endocrinol. Metab. 16: 107-110.
13. Gogoleva TE, Ademola JI, Wester RC, Magee PS, Maibach HI. 1999. Relative contributions of human skin layers to partitioning of chemicals with varying lipophilicity. In Percutaneous Absorption- Drugs- Cosmetics- Mechanism- Methodology, 3rd edn. Bronaugh R, Maibach HI (eds). Marcel Dekker: New York; Chapter 26, 451-462.
14. Hadgraft J, Peck J, Williams DG, Pugh WJ, and Allan G. 1996. Mechanisms of action of skin penetration enhancers/retarders: Azone and analogues. Int. J. Pharmaceut. 141: 17-25.
15. Hui X, Wester RC, Magee P, Maibach HI. 1995. Partitioning of chemicals from water into powdered human stratum corneum (callus): a model study. In Vitro Toxicol. 8(2): 159-167.
16. Hui X, Wester RC, Zhai H, Cashmore AK, Barbadillo S, Maibach HI. 2008. Chemical partitioning into powdered human stratum corneum: a useful in vitro model for studying interactions of chemicals and human skin. In Marzulli and Maibach's Dermatotoxicology, 7th edn, Zhai H, Wilhelm KP, Maibach HI (eds). CRC Press, Taylor and Francis Group: Boca Raton; 87-94.
17. Idson B 1983. Vehicle effects in percutaneous absorption. Drug Metab. Rev. 14: 207-222.
18. Kintz P, Tracqui A, Mangin P. 1992. Accidental death caused by the absorption of 2, 4-dichlorophenol through the skin. Arch. Toxicol. 66: 298-299.
19. Kalia YN, Guy RH. 2001. Modeling transdermal drug release. Adv. Drug Delivery Rev. 48: 159-172.
20. McMaster J, Maibach HI, Wester RC, Bucks DAW. 1985. Dose rubbing enhances in vivo dermal absorption? In Percutaneous Absorption, Mechanisms - Methodology - Drug Delivery, Bronaugh RL, Maibach HI (eds). Marcel Dekker, Inc: New York; 359-361.
21. Moody RP and Maibach HI. 2006. Skin decontamination: importance of the wash-in effect. Food Chem. Toxicol. 44: 1783-1788.
22. Ngo M, Maibach HI. 2012. Chapter 6: 15 Principles of percutaneous penetration. In ACS Books "Parameters for Pesticide QSAR and PBPK/PD Models for Human Risk Assessment" ACS Symposium Series. ACS Publications 1099: 67-86. Publication Date (Web): July 25, 2012, Chapter DOI: 10.1021/bk-2012-1099. ch006.
23. Noonan PK, Wester RC. 1989. Cutaneous metabolism of xenobiotics. In Percutaneous Absorption, Bronaugh RL, Maibach HI (eds). Marcel Dekker: New York; 53-75.
24. Purdon CH, Smith EW, Surber C, Pellanda C. 2005. Assessment of vehicle effects by skin stripping. In Percutaneous Penetration Enhancers, 2nd edn, Smith EW, Maibach HI (eds). CRC Press: Boca Raton; 299-309.
25. Quan D, Hui X, Maibach HI. 2010a. Chemical enhancements of transdermal drug delivery systems: advantages and challenges-part 1. TransDermal. March: 5-10.
26. Quan D, Hui X, Maibach HI. 2010b. Chemical enhancements of transdermal drug delivery systems: advantages and challenges-part 2. TransDermal. May: 15-20.
27. Raykar PV, Fung MC, Anderson BD. 1988. The role of protein and lipid domains in the uptake of solutes of human stratum corneum. Pharm. Res. 5: 140-150.
28. Ross JH, Driver JH, Harris SA, Maibach HI. 2005. Dermal absorption of 2, 4-D: a review of species differences. Regul. Toxicol. Pharmacol. 41: 82-91.
29. Rougier A, Dupuis D, Lotte C, Roguet R, Wester RC, Maibach HI. 1986. Regional variation in percutaneous absorption in man: measurement by the stripping method. Arch. Dermatol. Res. 278: 465-469.
30. Rougier A, Lotte C, Maibach HI. 1987a. The hairless rat: a relevant animal model to predict in vivo percutaneous absorption in human? J. Invest. Dermatol. 88: 577-581.
31. Rougier A, Lotte C, Maibach HI. 1987b. In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method. J. Pharm. Sci. 76: 451-545.
32. Rougier A, Rallis M, Krien P, Lotte C. 1990. In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning. Arch. Dermatol. Res. 282: 498-505.
33. Schalla W, Jamoulle J, Schaefer H. 1989. Localization of compounds in different skin layers and its use as an indicator of percutaneous absorption. In Percutaneous Absorption, Bronaugh RL, Maibach HI (eds). Marcel Dekker: New York; 283-312.
34. Scheuplein RJ and Blank IH. 1973. Mechanisms in percutaneous absorption. IV. Penetration of non-electrolytes (alcohols) from aqueous solutions and from pure liquids. J. Invest. Dermatol. 60: 286-296.
35. Songkro S 2009. An Overview of skin penetration enhancers: Penetration enhancing activity, skin irritation potential and mechanism of action. Songklanakarin J. Sci. Technol. 31: 299-321.
36. Surber C, Wilhelm KP, Hori M, Maibach HI, Guy RH. 1990a. Optimization of topical therapy: partitioning of drug into stratum corneum. Pharm. Res. 7: 1320-1324.
37. Surber C, Wilhelm KP, Maibach HI, Hall LL, and Guy RH. 1990b. Partitioning of chemicals into human stratum corneum: implications for risk assessment following dermal exposure. Fundam. Appl. Toxicol. 15: 99-107.
38. Wester RC, Bucks DW, Maibach HI, Anderson J. 1983. Polychlorinated biphenyls (PCBs): dermal absorption, systemic elimination, and dermal wash efficiency. J. Toxicol. Environ. Health 12: 511-519.
39. Wester RC, Hui X, Maibach HI.2006. In vivo human transfer of topical bioactive drug between individuals: estradiol. J. Invest. Dermatol. 126: 2190-2193.
40. Wester RC, Maibach HI. 1983. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. Drug Metab. Rev. 14: 169-205.
41. Wester RC, Maibach HI, Bucks D, McMaster J, Mobayen M, Sarason R, Moore A. 1990. Percutaneous absorption and skin decontamination of PCBs: in vitro studies with human skin and in vivo studies in the rhesus monkey. J. Toxicol. Environ. Health 31: 235-246.
42. Wester RC, Maibach HI, Hui X, Tanojo H. 1999. Progress Report of Environmental Management Science Program (DOE grant #DE-FG07-97ER62509): Bioavailability of Organic Solvents in Soils: Input into Biologically-based Dose-response Models for Human Risk Assessment. Available from: http://www.osti.gov/em52/1999projsum/59828.pdf (accessed 03 October 2012).
43. Wester RC, Maibach HI, Sedik L, Melendres J, Wade M. 1993. Percutaneous absorption of PCBs from soil: In vivo rhesus monkey, in vitro human skin, and binding to powdered human stratum corneum. J. Toxicol. Environ. Health 39: 375-382.
44. Wester RC, Melendres J, Logan F, Hui X, Maibach HI, Wade M, Huang KC. 1996. Percutaneous absorption of 2, 4-dichlorophenoxyacetic acid from soil with respect to soil load and skin contact time: In vivo absorption in rhesus monkey and in vitro absorption in human skin. J. Toxicol. Environ. Health 47: 335-344.
45. Wester RC, Melendres J, Sarason R, McMaster J, Maibach HI. 1991. Glyphosate skin binding, absorption, residual tissue distribution, and skin decontamination. Fundam. Appl. Toxicol. 16: 725-732.
46. Wester RC, Melendres J, Sedik L, Maibach HI, Riviere J. 1998. Percutaneous absorption of salicylic acid, theophylline, 2, 4-dimethylamine, diethyl hexyl phthalic acid and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo. Toxicol. Appl. Pharmacol. 151: 159-165.
47. Wester RC, Mobayen M, Maibach HI. 1987. In vivo and in vitro absorption and binding to powdered stratum corneum as methods to evaluate skin absorption of environmental chemical contaminants from ground and surface water. J. Toxicol. Environ. Health 21: 367-374.
48. Yerasi AB, Butts JD, Butts JD. 1997. Disposal of used fentanyl patches. Am. J. Health Syst. Pharm. 54: 85-86.
49. Zhai H, Maibach HI. 1996. Effect of barrier creams: human skin in vivo. Contact Dermatitis 35: 92-96.
50. Zhai H, Maibach HI. 2002. Barrier creams - skin protectants: can you protect skin? J. Cosmet. Dermatol. 1: 20-23.
51. Zhai H, Chan HP, Hui X, Maibach HI. 2008. Skin decontamination of glyphosate from human skin in vitro. Food Chem. Toxicol. 46: 2258-2260.